학술논문
A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant prostate cancer (mCRPC).
Document Type
Journal
Author
Calvo, Mariona; Penkov, Konstantin; Spira, Alexander I.; Candilejo, Irene Moreno; Shore, Neal D.; Zhang, Tian; Mellado-Gonzalez, Begona; Gordoa, Teresa Alonso; Rodriguez, Luis Paz-Ares; Tarantolo, Stefano R.; Soto, Juan Jose; Alter, Robert S.; Andreu-Vieyra, Claudia; Bowler, Timothy; Maity, Arnab K.; Hariharan, Subramanian; Schweizer, Michael Thomas
Source
Subject
Language
English
ISSN
15277755